(Q39710242)

14 September 2017

title

Delusional depressions: natural history and response to treatment (English)

1 reference

14 September 2017

Delusional Depressions: Natural History and Response to Treatment (English)

1 reference

https://api.crossref.org/works/10.1192/BJP.131.4.351

26 March 2023

author name string

S. J. Kantor

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A336128

26 March 2023

A. H. Glassman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A336128

26 March 2023

language of work or name

English

0 references

publication date

1 October 1977

1 reference

full work available at URL

14 September 2017

https://www.cambridge.org/core/services/aop-cambridge-core/content/view/S0007125000001860

1 reference

https://api.crossref.org/works/10.1192/BJP.131.4.351

British Journal of Psychiatry

26 March 2023

published in

1 reference

14 September 2017

volume

131

1 reference

14 September 2017

page(s)

351-360

1 reference

The physical treatments of depression: their indications and proper use

14 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1192/BJP.131.4.351

Norepinephrine metabolites as biochemical criteria for classifying depressive disorders and predicting responses to treatment: preliminary findings.

26 March 2023

2

1 reference

https://api.crossref.org/works/10.1192/BJP.131.4.351

Indications for Electro-Shock, Tofrānil and Psychotherapy in the Treatment of Depressions

26 March 2023

4

1 reference

https://api.crossref.org/works/10.1192/BJP.131.4.351

A CONTROLLED TRIAL OF IMIPRAMINE

26 March 2023

5

1 reference

https://api.crossref.org/works/10.1192/BJP.131.4.351

Nosology of depression and differential response to drugs

26 March 2023

6

1 reference

https://api.crossref.org/works/10.1192/BJP.131.4.351

Depressive Typologies and Response to Amitriptyline

26 March 2023

7

1 reference

https://api.crossref.org/works/10.1192/BJP.131.4.351

The Iowa 500. The first follow-up

26 March 2023

9

1 reference

https://api.crossref.org/works/10.1192/BJP.131.4.351

The Iowa 500. I. Diagnostic validity in mania, depression, and schizophrenia

26 March 2023

10

1 reference

https://api.crossref.org/works/10.1192/BJP.131.4.351

Catecholamine Metabolism, Depressive Illness, and Drug Response

26 March 2023

13

1 reference

https://api.crossref.org/works/10.1192/BJP.131.4.351

Biogenic amines and depression. Biochemical and pharmacological separation of two types of depression

26 March 2023

14

1 reference

https://api.crossref.org/works/10.1192/BJP.131.4.351

AMITRIPTYLINE IN DEPRESSIVE STATES: PHENOMENOLOGY AND PROGNOSTIC CONSIDERATIONS

26 March 2023

20

1 reference

https://api.crossref.org/works/10.1192/BJP.131.4.351

Prognostic factors in electric convulsive therapy

26 March 2023

23

1 reference

https://api.crossref.org/works/10.1192/BJP.131.4.351

26 March 2023

25

1 reference

https://api.crossref.org/works/10.1192/BJP.131.4.351

DIFFERENTIAL RESPONSE OF HOSPITALIZED DEPRESSED PATIENTS TO SOMATIC THERAPY

26 March 2023

27

1 reference

https://api.crossref.org/works/10.1192/BJP.131.4.351

Drug therapy of depression. Amitriptyline, perphenazine, and their combination in different syndromes

26 March 2023

28

1 reference

https://api.crossref.org/works/10.1192/BJP.131.4.351

Organic (Non-Drug) Therapy of Depression

26 March 2023

29

1 reference

https://api.crossref.org/works/10.1192/BJP.131.4.351

Reflections on the Specificity of Action of Anti-Depressants

26 March 2023

30

1 reference

https://api.crossref.org/works/10.1192/BJP.131.4.351

Variability of the Clinical Course of Primary Affective Disorder

26 March 2023

32

1 reference

https://api.crossref.org/works/10.1192/BJP.131.4.351

Serum dopamine-beta-hydroxylase activity in the affective psychoses and schizophrenia. Decreased activity in unipolar psychotically depressed patients

26 March 2023

33

1 reference

https://api.crossref.org/works/10.1192/BJP.131.4.351

Plasma levels of imipramine and clinical outcome

26 March 2023

35

1 reference

https://api.crossref.org/works/10.1192/BJP.131.4.351

Melancholia: A Historical Review

26 March 2023

36

1 reference

https://api.crossref.org/works/10.1192/BJP.131.4.351

Antidepressant response to tricyclics and urinary MHPG in unipolar patients. Clinical response to imipramine or amitriptyline

26 March 2023

38

1 reference

https://api.crossref.org/works/10.1192/BJP.131.4.351

Hospitalized depressions. Drugs or electrotherapy?

26 March 2023

40

1 reference

https://api.crossref.org/works/10.1192/BJP.131.4.351

Primary affective disorders. Selection efficiency of two sets of diagnostic criteria.

26 March 2023

42

1 reference

https://api.crossref.org/works/10.1192/BJP.131.4.351

A rating scale for depression

26 March 2023

43

1 reference

https://api.crossref.org/works/10.1192/BJP.131.4.351

The clinical pharmacology of imipramine. Implications for therapeutics

26 March 2023

44

1 reference

https://api.crossref.org/works/10.1192/BJP.131.4.351

A comparative trial of ECT and tofranil

26 March 2023

45

1 reference

https://api.crossref.org/works/10.1192/BJP.131.4.351

The efficacy of antidepressant drugs. A review of research (1958-1972).

26 March 2023

46

1 reference

https://api.crossref.org/works/10.1192/BJP.131.4.351

Clinical implications of imipramine plasma levels for depressive illness

26 March 2023

47

1 reference

https://api.crossref.org/works/10.1192/BJP.131.4.351

The modern treatment of depressive disorders

26 March 2023

50

1 reference

https://api.crossref.org/works/10.1192/BJP.131.4.351

Differential response to chlorpromazine, imipramine, and placebo. A study of subgroups of hospitalized depressed patients.

26 March 2023

51

1 reference

https://api.crossref.org/works/10.1192/BJP.131.4.351

A controlled comparison of imipramine and electroplexy

26 March 2023

55

1 reference

https://api.crossref.org/works/10.1192/BJP.131.4.351

The Significance of Psychotic Affective Disorders

26 March 2023

56

1 reference

https://api.crossref.org/works/10.1192/BJP.131.4.351

THE INFLUENCE OF CASE SELECTION AND DOSAGE IN AN ANTIDEPRESSANT DRUG TRIAL

26 March 2023

60

1 reference

https://api.crossref.org/works/10.1192/BJP.131.4.351

Diagnostic Criteria for Use in Psychiatric Research

26 March 2023

61

1 reference

https://api.crossref.org/works/10.1192/BJP.131.4.351

Imipramine (Tofranil) in depressive states: a controlled trial with inpatients

26 March 2023

62

1 reference

https://api.crossref.org/works/10.1192/BJP.131.4.351

Endogenomorphic depression. A conceptual and terminological revision

26 March 2023

63

1 reference

https://api.crossref.org/works/10.1192/BJP.131.4.351

The Iowa 500. II. A blind family history comparison of mania, depression, and schizophrenia

26 March 2023

65

1 reference

https://api.crossref.org/works/10.1192/BJP.131.4.351

A clinical analysis of the effects of tofranil in depression. Longitudinal and follow-up studies. Treatment of blood-relations

26 March 2023

69

1 reference

https://api.crossref.org/works/10.1192/BJP.131.4.351

26 March 2023

Identifiers

1 reference

14 September 2017

1 reference